These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

411 related items for PubMed ID: 9619777

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Use of conventional surfactant media as surrogates for FaSSIF in simulating in vivo dissolution of BCS class II drugs.
    Lehto P, Kortejärvi H, Liimatainen A, Ojala K, Kangas H, Hirvonen J, Tanninen VP, Peltonen L.
    Eur J Pharm Biopharm; 2011 Aug; 78(3):531-8. PubMed ID: 21329757
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Dissolution rate and apparent solubility of poorly soluble drugs in biorelevant dissolution media.
    Fagerberg JH, Tsinman O, Sun N, Tsinman K, Avdeef A, Bergström CA.
    Mol Pharm; 2010 Oct 04; 7(5):1419-30. PubMed ID: 20507160
    [Abstract] [Full Text] [Related]

  • 7. Dissolution behavior of various drugs in different FaSSIF versions.
    Klumpp L, Leigh M, Dressman J.
    Eur J Pharm Sci; 2020 Jan 15; 142():105138. PubMed ID: 31704344
    [Abstract] [Full Text] [Related]

  • 8. Drug release from spray layered and coated drug-containing beads: effects of pH and comparison of different dissolution methods.
    Sorasuchart W, Wardrop J, Ayres JW.
    Drug Dev Ind Pharm; 1999 Oct 15; 25(10):1093-8. PubMed ID: 10529889
    [Abstract] [Full Text] [Related]

  • 9. Biorelevant dissolution testing of a weak base: Interlaboratory reproducibility and investigation of parameters controlling in vitro precipitation.
    Berben P, Ashworth L, Beato S, Bevernage J, Bruel JL, Butler J, Dressman J, Schäfer K, Hutchins P, Klumpp L, Mann J, Nicolai J, Ojala K, Patel S, Powell S, Rosenblatt K, Tomaszewska I, Williams J, Augustijns P.
    Eur J Pharm Biopharm; 2019 Jul 15; 140():141-148. PubMed ID: 31051249
    [Abstract] [Full Text] [Related]

  • 10. Interaction between fed gastric media (Ensure Plus®) and different hypromellose based caffeine controlled release tablets: comparison and mechanistic study of caffeine release in fed and fasted media versus water using the USP dissolution apparatus 3.
    Franek F, Holm P, Larsen F, Steffansen B.
    Int J Pharm; 2014 Jan 30; 461(1-2):419-26. PubMed ID: 24342711
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The conflict between in vitro release studies in human biorelevant media and the in vivo exposure in rats of the lipophilic compound fenofibrate.
    Do TT, Van Speybroeck M, Mols R, Annaert P, Martens J, Van Humbeeck J, Vermant J, Augustijns P, Van den Mooter G.
    Int J Pharm; 2011 Jul 29; 414(1-2):118-24. PubMed ID: 21596119
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Fasted and fed state human duodenal fluids: Characterization, drug solubility, and comparison to simulated fluids and with human bioavailability.
    Dahlgren D, Venczel M, Ridoux JP, Skjöld C, Müllertz A, Holm R, Augustijns P, Hellström PM, Lennernäs H.
    Eur J Pharm Biopharm; 2021 Jun 29; 163():240-251. PubMed ID: 33872761
    [Abstract] [Full Text] [Related]

  • 16. In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib.
    Tsume Y, Takeuchi S, Matsui K, Amidon GE, Amidon GL.
    Eur J Pharm Sci; 2015 Aug 30; 76():203-12. PubMed ID: 25978875
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prediction of food effect on in vitro drug dissolution into biorelevant media: Contributions of solubility enhancement and relatively low colloid diffusivity.
    Jamil R, Polli JE.
    Eur J Pharm Sci; 2022 Oct 01; 177():106274. PubMed ID: 35944878
    [Abstract] [Full Text] [Related]

  • 19. Effects of gastric pH on oral drug absorption: In vitro assessment using a dissolution/permeation system reflecting the gastric dissolution process.
    Kataoka M, Fukahori M, Ikemura A, Kubota A, Higashino H, Sakuma S, Yamashita S.
    Eur J Pharm Biopharm; 2016 Apr 01; 101():103-11. PubMed ID: 26873006
    [Abstract] [Full Text] [Related]

  • 20. Dissolution properties of co-amorphous drug-amino acid formulations in buffer and biorelevant media.
    Heikkinen AT, DeClerck L, Löbmann K, Grohganz H, Rades T, Laitinen R.
    Pharmazie; 2015 Jul 01; 70(7):452-7. PubMed ID: 26373205
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.